RhumbLine Advisers’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-113,532
| Closed | -$96K | – | 3155 |
|
2020
Q1 | $96K | Hold |
113,532
| – | – | ﹤0.01% | 2788 |
|
2019
Q4 | $186K | Buy |
113,532
+5,536
| +5% | +$9.07K | ﹤0.01% | 2771 |
|
2019
Q3 | $120K | Sell |
107,996
-160
| -0.1% | -$178 | ﹤0.01% | 2857 |
|
2019
Q2 | $134K | Buy |
108,156
+41,294
| +62% | +$51.2K | ﹤0.01% | 2879 |
|
2019
Q1 | $96K | Sell |
66,862
-1,435
| -2% | -$2.06K | ﹤0.01% | 2865 |
|
2018
Q4 | $81K | Buy |
68,297
+23,160
| +51% | +$27.5K | ﹤0.01% | 2903 |
|
2018
Q3 | $61K | Sell |
45,137
-3,275
| -7% | -$4.43K | ﹤0.01% | 2900 |
|
2018
Q2 | $111K | Buy |
48,412
+15,100
| +45% | +$34.6K | ﹤0.01% | 2861 |
|
2018
Q1 | $50K | Sell |
33,312
-100
| -0.3% | -$150 | ﹤0.01% | 2793 |
|
2017
Q4 | $25K | Sell |
33,412
-30,664
| -48% | -$22.9K | ﹤0.01% | 2827 |
|
2017
Q3 | $74K | Buy |
64,076
+2,761
| +5% | +$3.19K | ﹤0.01% | 2878 |
|
2017
Q2 | $107K | Sell |
61,315
-2,553
| -4% | -$4.46K | ﹤0.01% | 2889 |
|
2017
Q1 | $169K | Buy |
63,868
+22,523
| +54% | +$59.6K | ﹤0.01% | 2692 |
|
2016
Q4 | $176K | Sell |
41,345
-17,186
| -29% | -$73.2K | ﹤0.01% | 2702 |
|
2016
Q3 | $156K | Buy |
58,531
+26,800
| +84% | +$71.4K | ﹤0.01% | 2747 |
|
2016
Q2 | $56K | Sell |
31,731
-17,765
| -36% | -$31.4K | ﹤0.01% | 2960 |
|
2016
Q1 | $115K | Buy |
49,496
+2,645
| +6% | +$6.15K | ﹤0.01% | 2868 |
|
2015
Q4 | $163K | Buy |
46,851
+6,330
| +16% | +$22K | ﹤0.01% | 2861 |
|
2015
Q3 | $248K | Buy |
40,521
+1,973
| +5% | +$12.1K | ﹤0.01% | 2664 |
|
2015
Q2 | $254K | Buy |
38,548
+9,065
| +31% | +$59.7K | ﹤0.01% | 2760 |
|
2015
Q1 | $210K | Buy |
+29,483
| New | +$210K | ﹤0.01% | 2817 |
|